Oral Akkermansia muciniphila may ameliorates immune dysregulation in a murine model of streptozotocin-induced type 1 diabetes

doi:10.4239/wjd.v16.i12.111771

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 12

This Article

(42)

(34)

(0)

(11)

(1)

(718)

(2)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Diabetes. Dec 15, 2025; 16(12): 111771
Published online Dec 15, 2025. doi: 10.4239/wjd.v16.i12.111771

Full Size Figure Download Figure

Figure 5 Correlation analysis heatmap. ^aP < 0.05. ^bP < 0.01. ^cP < 0.001. CD: Cluster of differentiation; FoxP3: Forkhead box P3; Treg: Regulatory T; TGF-β: Transforming growth factor-beta; TNF-α: Tumor necrosis factor-alpha; IFN-γ: Interferon-gamma; IL-4: Interleukin-4; ZO-1: Zonula occludens-1.

Citation: Huang BJ, Guo S, Lin XY, Li YH, Ma HM, Zhang J, Chen QL. Oral Akkermansia muciniphila may ameliorates immune dysregulation in a murine model of streptozotocin-induced type 1 diabetes. World J Diabetes 2025; 16(12): 111771
URL: https://www.wjgnet.com/1948-9358/full/v16/i12/111771.htm
DOI: https://dx.doi.org/10.4239/wjd.v16.i12.111771

Huang BJ, Guo S, Lin XY, Li YH, Ma HM, Zhang J, Chen QL. Oral Akkermansia muciniphila may ameliorates immune dysregulation in a murine model of streptozotocin-induced type 1 diabetes. World J Diabetes 2025; 16(12): 111771 [PMID: 41480616 DOI: 10.4239/wjd.v16.i12.111771]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.